心得宁治疗与系统性红斑狼疮样综合征及因子 XIII 抑制剂相关。
Practolol therapy associated with a systemic lupus erythematosus-like syndrome and an inhibitor to factor XIII.
作者信息
Milner G R, Holt P J, Bottomley J, Maciver J E
出版信息
J Clin Pathol. 1977 Aug;30(8):770-3. doi: 10.1136/jcp.30.8.770.
Abstract
A patient is described who had an inhibitor to coagulation factor XIII associated with serum autoantibodies to certain tissues. The relationship of these abnormal findings to practolol therapy suggests that this was practolol-induced lupus erythematosus. Further investigations delineating the site of action of the inhibitor to factor XIII are reported.
摘要
本文描述了一名患者，其体内存在凝血因子 XIII 抑制剂，并伴有针对某些组织的血清自身抗体。这些异常发现与心得宁治疗之间的关系提示这是心得宁诱发的红斑狼疮。本文还报告了进一步明确因子 XIII 抑制剂作用位点的研究。
相似文献
1
Practolol therapy associated with a systemic lupus erythematosus-like syndrome and an inhibitor to factor XIII.心得宁治疗与系统性红斑狼疮样综合征及因子 XIII 抑制剂相关。
J Clin Pathol. 1977 Aug;30(8):770-3. doi: 10.1136/jcp.30.8.770.
2
[Practolol-induced systemic lupus erythematosus].心得宁诱发的系统性红斑狼疮
Harefuah. 1976 Aug;91(3-4):83-4.
3
[Drug-induced systemic lupus erythematosus (author's transl)].药物性系统性红斑狼疮（作者译）
Immun Infekt. 1977 Aug;5(4):142-56.
4
Intracranial hemorrhage in systemic lupus erythematosus associated with an autoantibody against actor XIII.系统性红斑狼疮伴抗凝血因子ⅩⅢ自身抗体相关的颅内出血
Thromb Haemost. 2002 Dec;88(6):919-23.
5
SLE syndrome with keratoconjunctivitis sicca, a side-effect of practolol [proceedings].伴有干燥性角结膜炎的系统性红斑狼疮综合征，心得宁的一种副作用[会议记录]
Ophthalmologica. 1977;175(1):40.
6
Practolol-induced SLE-like syndrome.心得宁诱发的系统性红斑狼疮样综合征。
Proc R Soc Med. 1976 Jan;69(1):61-2. doi: 10.1177/003591577606900131.
7
Characterization of an acquired IgG inhibitor of coagulation factor XIII in a patient with systemic lupus erythematosus.系统性红斑狼疮患者中一种获得性凝血因子 XIII IgG 抑制剂的特征分析。
Br J Haematol. 1996 Jun;93(3):700-3. doi: 10.1046/j.1365-2141.1996.d01-1678.x.
8
Hypotensive agents, beta-blockers, and drug-induced lupus.降压药、β受体阻滞剂与药物性狼疮。
Br Med J (Clin Res Ed). 1982 May 8;284(6326):1358-9. doi: 10.1136/bmj.284.6326.1358.
9
Letter: cutaneous and ocular reactions to practolol.信函：心得宁的皮肤及眼部反应。
Br Med J. 1974 Dec 14;4(5945):653. doi: 10.1136/bmj.4.5945.653.
10
Editorial: side effects of practolol.社论：心得宁的副作用
Br Med J. 1975 Jun 14;2(5971):577-8.
引用本文的文献
1
Nonhemophiliac musculoskeletal pseudotumor.非血友病性肌肉骨骼假瘤
J Vasc Surg Cases. 2015 Jun 19;1(2):187-190. doi: 10.1016/j.jvsc.2015.04.007. eCollection 2015 Jun.
2
New developments in the management of congenital Factor XIII deficiency.先天性因子 XIII 缺乏症治疗的新进展
J Blood Med. 2013 May 28;4:65-73. doi: 10.2147/JBM.S32693. Print 2013.
3
Hemorrhagic-acquired factor XIII deficiency associated with tocilizumab for treatment of rheumatoid arthritis.与托珠单抗治疗类风湿关节炎相关的获得性凝血因子 XIII 缺乏症。
Int J Hematol. 2012 Dec;96(6):781-5. doi: 10.1007/s12185-012-1191-x. Epub 2012 Oct 16.
4
Acquired FXIII inhibitors: a systematic review.获得性 FXIII 抑制剂：系统评价。
J Thromb Thrombolysis. 2013 Jul;36(1):109-14. doi: 10.1007/s11239-012-0818-3.
5
Case report of an acquired factor XIII inhibitor: diagnosis and management.一例获得性凝血因子 XIII 抑制剂的病例报告：诊断与处理
Proc (Bayl Univ Med Cent). 2006 Jul;19(3):221-3. doi: 10.1080/08998280.2006.11928166.
6
Acetylator phenotype and lupus erythematosus.乙酰化酶表型与红斑狼疮
Clin Pharmacokinet. 1981 Mar-Apr;6(2):118-34. doi: 10.2165/00003088-198106020-00003.
本文引用的文献
1
PLASMA FIBRIN STABILIZING FACTOR ACTIVITY IN VARIOUS DISEASES.各种疾病中的血浆纤维蛋白稳定因子活性
Blood. 1964 May;23:669-78.
2
Circulating anticoagulants: a study of 40 cases and a review of the literature.循环抗凝物质：40例研究及文献综述
Medicine (Baltimore). 1961 May;40:145-202.
3
A pathological inhibitor of fibrin cross-linking.一种纤维蛋白交联的病理性抑制剂。
J Clin Invest. 1968 Feb;47(2):268-73. doi: 10.1172/JCI105723.
4
An acquired inhibitor to factor XIII.一种获得性凝血因子 XIII 抑制剂。
Arch Intern Med. 1972 Nov;130(5):772-7.
5
Haemorrhagic syndrome of autoimmune origin with a specific inhibitor against fibrin stabilizing factor (factor XIII).具有针对纤维蛋白稳定因子（因子 XIII）的特异性抑制剂的自身免疫性出血综合征。
Br J Haematol. 1972 Jul;23(1):17-27. doi: 10.1111/j.1365-2141.1972.tb03455.x.
6
Circulating anticoagulants to factor VIII. Immunochemical studies and clinical response to factor VIII concentrates.抗凝血因子VIII的循环抗凝物质。免疫化学研究及对凝血因子VIII浓缩物的临床反应。
Am J Med. 1970 Dec;49(6):742-52. doi: 10.1016/s0002-9343(70)80056-0.
7
Diagnostic and genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation.基于胺掺入的新检测方法对纤维蛋白稳定因子的诊断和遗传学研究。
J Clin Invest. 1969 Jun;48(6):1054-64. doi: 10.1172/JCI106061.
8
A new haemorrhagic disorder with defective fibrin stabilization and cryofibrinogenaemia.一种伴有纤维蛋白稳定缺陷和冷纤维蛋白原血症的新型出血性疾病。
Br J Haematol. 1974 Feb;26(2):269-84. doi: 10.1111/j.1365-2141.1974.tb00472.x.
9
Circulating anticoagulants against factors IX and XI in systemic lupus erythematosus.系统性红斑狼疮中针对因子IX和XI的循环抗凝物质
Ann Intern Med. 1972 Oct;77(4):543-8. doi: 10.7326/0003-4819-77-4-543.
Zotero 插件